AI tumor board review for solid tumors
Bringing tumor board confidence to every patient
Every perspective. Every disagreement.Every source.
Everyboard gives the physician treating a patient with any solid tumor a written review from every specialty on the board: every position in its own words, where they disagree, the evidence behind them, and what the record still needs.
Each position is written by an AI model configured to one specialty, so the treating physician sees how every discipline weighs the case.
Who it is for
For the physicians who treat cancer close to home
Their patients get the structure of a multidisciplinary board from the physician they already see.
- Oncologists and urologists in physician-owned practices
- Every discipline’s reasoning on a case, in writing, before the plan is set.
- Practices that refer to academic centers
- The review can travel with the referral, so the receiving team starts from every discipline’s position and the questions still open.
What it is
A written deliberation summary for each patient
One document per case, laid out the way a tumor board works through it.
- The case as the records state it, with every gap marked and none filled in.
- Each specialty’s position in its own words, and where it disagreed with another.
- What the record still needs, and what to do under each possible answer.
- Every source the board drew on, marked by how it was used, with a link to each.
Clinical deliberation summary · Decision support, not a clinical decision · Research-drafted — not clinician-verified
Everyboard · GU Tumor Board · Deliberation Summary
70-year-old Grade Group 2 prostate cancer
Primary recommendation
No definitive call until serum testosterone, prior-therapy timeline, and formal cM adjudication return — then treat as conditional framework below.
Medical Oncologist
Where this specialty disagreed
- Partial agreementwith Radiologist: Agree that imaging shows progression and suspicious para-aortic disease, but disagree with describing this as CHAARTED high-volume disease.
- Dissentwith Nuclear Medicine: The PSMA read is useful, but present-tense RLT eligibility is premature and wrong for the unresolved disease state.
Why a board
Every perspective, before the plan is set
- In every solid tumor, the hard cases often have more than one reasonable path, and each specialty weighs them differently. A tumor board exists to put those views side by side before anyone commits.
- A split is information. Everyboard records who disagreed and why, instead of averaging the difference away.
- For the practice, that means keeping the complex cases you can treat and sending better-prepared referrals for the ones you can’t.
- Everyboard is clinical decision support. The treating physician makes the call, and every position shows its basis so it can be checked independently.
How it works
From the records to the summary, in four steps
- 1Add the recordsClinic notes, pathology, imaging reports and labs, or the case in your own words.
- 2Confirm the chartCheck each value against its source, and settle every gap before anything runs.
- 3Run the boardEach specialty forms a position on the confirmed record, then answers the others.
- 4Read the summaryPositions, disagreements, evidence and next steps, in one document.
Why here
Every specialty’s view, close to home
Most people with cancer are treated in their own community, by oncologists who know them. Everyboard gives those physicians a written tumor board review for any solid tumor, before the plan is set.
1.92 million
new solid-tumor cases expected in the US in 2026, 91% of all new cancers
4.5–52%
of reviewed cases where a multidisciplinary tumor board changed the management plan, across published studies
55%
of out-of-state patients seen for urologic cancer at Fred Hutch had flown to get there
A tumor board puts every specialty’s reasoning on a case before treatment begins, and that review changes the plan more often than most people expect. Everyboard brings it to the treating physician in writing: each specialty’s position and where they disagree, with every source cited. The physician makes the call.
We’re based in the Pacific Northwest, where specialty cancer care can mean a flight, so we’re starting here with independent practices from Oregon to Alaska. Cases that can be settled close to home are. Cases that need an academic center arrive with each discipline’s position and the open questions already documented.
Access is by request
Tell us about your practice. We read every request and will get back to you within two business days.
Request access